当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析 - 现金流量表

圣湘生物

(688289)

  

流通市值:118.08亿  总市值:118.08亿
流通股本:5.79亿   总股本:5.79亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金754,411,397.4373,157,695.471,732,266,862.671,137,919,974.69
  收到的税费返还2,075,796.951,844,873.61,050,811.341,117,122.32
  收到其他与经营活动有关的现金29,242,015.389,525,123.98149,949,373.26125,446,235.09
  经营活动现金流入小计785,729,209.73384,527,693.051,883,267,047.231,304,483,332.1
  购买商品、接受劳务支付的现金274,310,770.04106,202,179.92375,469,613.21396,247,166.85
  支付给职工以及为职工支付的现金292,071,383.83166,159,172.47515,320,930.5384,231,263.48
  支付的各项税费77,772,148.1331,163,311.61113,392,351.73122,139,740.61
  支付其他与经营活动有关的现金284,421,748.75114,819,675.52604,636,295.68411,844,025.77
  经营活动现金流出小计928,576,050.75418,344,339.521,608,819,191.121,314,462,196.71
  经营活动产生的现金流量净额-142,846,841.02-33,816,646.47274,447,856.11-9,978,864.61
二、投资活动产生的现金流量:
  收回投资收到的现金550,459,322.485,802,492.931,530,794,631.181,612,760,522.52
  取得投资收益收到的现金4,570,623.12,512,502.9214,609,516.233,310,578.82
  处置固定资产、无形资产和其他长期资产收回的现金净额430,695.32-251,107.98297,282.48
  处置子公司及其他营业单位收到的现金净额----58,278,161.51
  收到的其他与投资活动有关的现金160,406,184.76167,666,681.61--
  投资活动现金流入小计715,866,825.58255,981,677.461,545,655,255.361,588,090,222.31
  购建固定资产、无形资产和其他长期资产支付的现金109,025,361.8347,881,221.18421,104,874.3178,366,430.37
  投资支付的现金1,506,333,333.34795,600,0001,167,125,1811,380,749,768.56
  取得子公司及其他营业单位支付的现金--1,068,642.86-
  支付其他与投资活动有关的现金--58,278,161.51-
  投资活动现金流出小计1,615,358,695.17843,481,221.181,647,576,859.671,559,116,198.93
  投资活动产生的现金流量净额-899,491,869.59-587,499,543.72-101,921,604.3128,974,023.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金--29,046,986.68-
  其中:子公司吸收少数股东投资收到的现金--7,595,127.72-
  取得借款收到的现金942,782,275817,000,000403,130,000408,130,000
  收到其他与筹资活动有关的现金6,302,199.136,302,199.13-21,451,858.96
  筹资活动现金流入小计949,084,474.13823,302,199.13432,176,986.68429,581,858.96
  偿还债务支付的现金394,130,000394,130,0009,000,00014,000,000
  分配股利、利润或偿付利息支付的现金169,338,392.056,315,276.8268,401,272.76258,228,658.62
  支付其他与筹资活动有关的现金16,687,372.414,715,521.7422,285,064.228,066,350.41
  筹资活动现金流出小计580,155,764.45415,160,798.54299,686,336.98280,295,009.03
  筹资活动产生的现金流量净额368,928,709.68408,141,400.59132,490,649.7149,286,849.93
四、汇率变动对现金及现金等价物的影响1,279,806.12185,714.52-3,296.46-4,560,459.12
五、现金及现金等价物净增加额-672,130,194.81-212,989,075.08305,013,605.04163,721,549.58
  加:期初现金及现金等价物余额4,476,628,016.924,476,628,016.924,171,614,411.884,171,614,411.88
  期末现金及现金等价物余额3,804,497,822.114,263,638,941.844,476,628,016.924,335,335,961.46
补充资料:
  净利润142,740,148.15-226,272,700.73-
  资产减值准备8,604,506.41--43,832,062.69-
  固定资产和投资性房地产折旧73,201,522.15-112,549,189.71-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧73,201,522.15-112,549,189.71-
  无形资产摊销19,430,871.45-29,898,558.16-
  长期待摊费用摊销12,494,242.34-19,100,906.43-
  处置固定资产、无形资产和其他长期资产的损失3,044,178.72-2,362,321.35-
  固定资产报废损失91,940-1,843,247.35-
  公允价值变动损失-47,493,750.56--8,408,087.48-
  财务费用-34,065,418.92-18,395,334.85-
  投资损失24,953,300.33-33,698,078.42-
  递延所得税32,473,204.4-1,812,202.2-
  其中:递延所得税资产减少562,014.25-5,716,598.49-
    递延所得税负债增加31,911,190.15--3,904,396.29-
  存货的减少6,934,895.17-36,459,148.26-
  经营性应收项目的减少-176,965,839.41-153,010,557.96-
  经营性应付项目的增加-165,602,089.86--305,374,504.73-
  其他-32,768,898.14--27,166,664.51-
  现金的期末余额3,804,497,822.11-4,476,628,016.92-
  减:现金的期初余额4,476,628,016.92-4,171,614,411.88-
  现金及现金等价物的净增加额-672,130,194.81-305,013,605.04-
公告日期2025-08-302025-04-292025-04-292024-10-24
审计意见(境内)标准无保留意见
TOP↑